Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.

Elizabeth C Okafor, Katelyn A Pastick, Radha Rajasingham

Author Information

Elizabeth C Okafor: University of Minnesota, Minneapolis, MN radha@umn.edu.
Katelyn A Pastick: University of Minnesota, Minneapolis, MN radha@umn.edu.
Radha Rajasingham: University of Minnesota, Minneapolis, MN radha@umn.edu.

PMID: 32668109 DOI: 10.1056/NEJMc2023617

No abstract text available.

K23 AI138851/NIAID NIH HHS

Betacoronavirus

COVID-19

Coronavirus Infections

Humans

Hydroxychloroquine

Pandemics

Pneumonia, Viral

SARS-CoV-2

COVID-19 Drug Treatment

Hydroxychloroquine

Letter Comment

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.Covid-19: Hydroxychloroquine was ineffective as postexposure prophylaxis, study finds.A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.Hydroxychloroquine as Prophylaxis for COVID-19: A Review.HIV postexposure prophylaxis during COVID-19.Postexposure-vaccine-prophylaxis against COVID-19.Eua for Regen-Cov Now Includes COVID-19 Postexposure Prophylaxis.

No available data.